Pharmaceuticals

We want to change the way iron deficiency is prevented and treated and have brought to market innovative treatments for patients suffering from iron deficiency and iron deficiency anaemia.

Our ambition is to become the world’s preferred partner in the management of iron deficiency and iron deficiency anaemia. We strive to achieve this partnership by simplifying the treatment, spearheading the improvement of patient safety, and driving the expanded use of high-dose intravenous iron across therapy fields.

Improved patient outcomes

We have significantly advanced the field by conducting pivotal trials and demonstrating the relative benefits of intravenous iron in large head-to-head RCTs. Our work has been instrumental in highlighting the advantages of high-dose intravenous iron, including improved patient outcomes, fewer hospitalisations and blood transfusions, enhanced healthcare utilisation, and increased patient satisfaction.

Monofer® - ferric derisomaltose 100 mg /ml

Read about our intravenous iron for the treatment of iron deficiency and iron deficiency anaemia.

Diafer® - ferric derisomaltose 50mg/ml

50 mg/ml solution for injection.

Cosmofer® - low Mw iron dextran

Iron dextran

IRON DEFICIENCY

Iron is essential for carrying and storing oxygen in our blood, for energy production, and for cell growth. Learn about the effects of iron deficiency on our health.

PHARMACOSMOS IS...

A global pioneer in carbohydrate chemistry and a leader in the development of innovative treatments for patients suffering from iron deficiency and iron deficiency anaemia.

Carbohydrates

We are a leader in the development and production of glucose poly- and oligosaccharides and their derivatives for pharmaceutical, high-tech and medical use.

Animal Health

Our expertise in iron extends to veterinary medicine, where we produce ferric hydroxide complex according to the same standards as required for human medicines.